Skip to content

GSK, BMS, J&J top ethical ranking list by Covalence

GlaxoSmithKline is at the top of ethical-monitoring firm Covalence's ranking list, followed by Bristol-Myers Squibb and Johnson & Johnson. The quarterly report, which ranks the top 10 highest-ranking pharmas, reveals that the amount of revenue a company earns does not…

More

The Ethically Challenged: How Pharma Fares

In these ethically challenging times, which drugmaker has its act together? Covalence, a research group based in Geneva that tracks ethical reputations, recently released its quarterly update in which various industrial sectors were examined. The firm compiles its rankings and…

More

Poison suisse pour paysans du Sud

Interdit d'utilisation en Suisse et dans plusieurs pays européens à  cause de sa dangerosité, le Paraquat continue néanmoins à  faire les beaux jours de la multinationale suisse Syngenta. Ce puissant herbicide est en effet largement utilisé dans les pays du…

More

Pepsi: Repairing a Poisoned Reputation in India

Indra K. Nooyi says she still feels guilty filling a bathtub with water. It sounds far-fetched coming from the chief executive of a major multinational corporation, until you consider her early years. Nooyi, the chief executive of PepsiCo Inc. (PEP),…

More

The Blue Gold

Nowadays the problem of the water is becoming more important than ever before. After the World Water Day on 22th March 2007 many international organisations such as United Nations, WWF and others launched an alarm for the scarcity of water…

More

Ethical reputations of top pharma firms revealed

The latest ethical reputations of the world's largest pharmaceutical companies have been revealed, with GlaxoSmithKline (GSK) emerging as big pharma's Mother Theresa, according to a recently-released compilation by Geneva-based ethical-monitoring firm Covalence. Interestingly, earning power and ethical nature do not…

More

Shifting Gears, GM Now Sees Green

Five years ago, General Motors Corp. gave the world the Hummer H2, a vehicle so fuel-thirsty that GM took advantage of a federal loophole that allowed the company not to publish its estimated mileage. Today, the No. 1 U.S. auto…

More
Back To Top